Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coronavirus Antigen Testing Gets Green Light In Germany

Boost for testing volumes and Paul-Ehrlich-Institut role gets industry support

Executive Summary

Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.

You may also be interested in...



US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production

Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.

Under-Pressure German COVID-19 Labs Urge Test Strategy Reset

With daily German COVID-19 infection levels refusing to decline, testing labs are urging the health ministry to take some of the pressure off them.

Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement

German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT142788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel